These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14666698)

  • 21. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Knaus EE
    Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
    Velázquez C; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and cyclooxygenase inhibitory activities of linear 1-(methanesulfonylphenyl or benzenesulfonamido)-2-(pyridyl)acetylene regioisomers.
    Chowdhury MA; Dong Y; Chen QH; Abdellatif KR; Knaus EE
    Bioorg Med Chem; 2008 Feb; 16(4):1948-56. PubMed ID: 18023187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP.
    Johnson KP; Rowe GC; Jackson BA; D'Agustino JL; Campbell PE; Guillory BO; Williams MV; Matthews QL; McKay J; Charles GM; Verret CR; Deleon M; Johnson DE; Cooke DB
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1039-45. PubMed ID: 11785654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Styrylheterocycles as a novel class inhibitor of cyclooxygenase-2-mediated prostaglandin E(2) production.
    Lee SK; Park EJ; Lee E; Min HY; Kim EY; Lee T; Kim S
    Bioorg Med Chem Lett; 2004 May; 14(9):2105-8. PubMed ID: 15080988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK; Narayanan BA; Reddy BS
    Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines.
    Buecher B; Bouancheau D; Broquet A; Bezieau S; Denis MG; Bonnet C; Heymann MF; Jarry A; Galmiche JP; Blottière HM
    Anticancer Res; 2005; 25(1A):225-33. PubMed ID: 15816542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
    Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S
    J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
    Santagati A; Granata G; Marrazzo A; Santagati M
    Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.
    Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
    Singh SK; Vobbalareddy S; Kalleda SR; Rajjak SA; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Bhamidipati R; Ramanujam R; Akella V; Yeleswarapu KR
    Org Biomol Chem; 2004 Sep; 2(17):2442-50. PubMed ID: 15326524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells.
    Fiebich BL; Grozdeva M; Hess S; Hüll M; Danesch U; Bodensieck A; Bauer R
    Planta Med; 2005 Jan; 71(1):12-9. PubMed ID: 15678367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
    Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
    J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
    Uddin MJ; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.